iCIMS is pleased to announce that it has been granted a US patent for the technology underlying its award-winning software platform LATTICE.
This comes on the heels of iCIMS being announced as the inaugural winner of the Medical Software Industry Association (MSIA) Best Innovation by a Member Company 2019. See article here.
iCIMS won the award for its implementation of a LATTICE powered solution for the Sydney Adventist Hospital’s Cancer Centre of Excellence that enabled automation of the various multidisciplinary team meetings that form part of the core offering in the San’s fight against cancer.
The power of the LATTICE technology was demonstrated with a seamless move to remote team collaboration due to the CoVid-19 crisis. Ali Besiso, iCIMS’ Managing Director was pleased with the result, “For one of our major clients to be able to bring a new tumour stream online, and do it remotely, during this crisis shows the power of our infrastructure and its unique way of very quickly building and deploying clinical systems, a uniqueness that has been acknowledged by the recent granting of a Patent for our technology by the United States Patent and Trade Mark Office.”
